LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

CardioNXT

Technology designed to target and treat the ectopic cardiac tissue that contributes to atrial fibrillation.

Get a Demo and See the Full Profile

Get a demo today to see profiles of CardioNXT plus 6116 other startups.

Learn More About CardioNXT

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups

More